Biotechnology

Report: The Japanese Model for a Bioeconomy

About the Report:

Report: Update on cell technology, cell therapy, tissue engineering and gene therapy in Japan

This report is an updated edition of a first study on cell technology, cell therapy, tissue engineering and gene therapy in Japan published in 2015.

Report: White Biotechnology

This report describes some of the mechanisms by which EU SMEs can get involved in Biotechnology in Japan

Success Story in Japan of the British Biotech SME Sphere Fluidics

Success Story: Metabolomic Discoveries / SME / Local sales representative to identify new potential partners

Metabolomic Discoveries - DE

“Local sales representative t

Success Story: Remembrane SrL / SME / Patience is a key word when dealing with Japan

Remembrane SrL – from Italy

“Patience is a key word when d

Success Story: Sphere Fluidics / SME / Finding partners in Japan

Sphere Fluidics – from the UK

Sphere Fluidics is a British Life Sc

Webinar 101: Biotech Market in Japan

SEP

2017

Which opportunities does the Biopharmaceutical market in Japan offer to E

10:30 - 11:30

Webinar 145: The Biopharmaceuticals sector in Japan

OCT

2019

How can I access the Japanese market as a novel biopharmaceutical product

10:30 - 11:30

Webinar 179: Latest trends in biotechnology research in Japan

SEP

2021

How is Japanese biotech R&D structured, who are the key stakehold

10:30 - 11:30

Webinar 41: Cell technology, cell therapy, tissue engineering and gene therapy in Japan

APR

2015

What’s on in Japan regarding cell technology and gene therapy, an

10:30 - 11:30

Webinar 64: White Biotech

MAR

2016

Japan is among global leaders in industrial biotechnology and looking for

10:30 - 11:30

Time in Brussels

Time in Tokyo

Exchange rate

1€ = 183,929 JPY

EU-Japan Centre for Industrial Cooperation

Joint venture established in 1987 by the European Commission (DG GROW) and the Japanese Government (METI) for promoting all forms of industrial, trade and investment cooperation between the EU and Japan.